Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Forensic applicability of autosomal insertion/deletion loci in Chinese Daur ethnic group and genetic affinity evaluations between Daur group and reference populations.

Legal medicine (Tokyo, Japan)·2020
Same author

Dental caries experience and related risk indicators of 12-year-old students in Jilin, China.

Medicine·2020
Same author

The role of NAC transcription factor in plant cold response.

Plant signaling & behavior·2020
Same author

Monocyte-Derived Leukemia-Associated Macrophages Facilitate Extramedullary Distribution of T-cell Acute Lymphoblastic Leukemia Cells.

Cancer research·2020
Same author

An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.

Cancer gene therapy·2020
Same author

A population-based survey for dietary patterns and prediabetes among 7555 Chinese adults in urban and rural areas in Jiangsu Province.

Scientific reports·2020

相关实验视频

Updated: Jun 11, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.8K

针对多发性骨髓瘤治疗的GPRC5D进行向.

Dian Zhou1,2, Ying Wang1,2, Chong Chen1,2

  • 1Department of Hematology, Affiliated Hospital of Xuzhou Medical University, #99 West Huaihai Road, Xuzhou, 221002, Jiangsu, China.

Journal of hematology & oncology
|September 28, 2024
PubMed
概括

G蛋白结合受体类C组5成员D (GPRC5D) 是多发性骨髓瘤 (MM) 的一个有前途的免疫治疗点. 研究正在探索针对GPRC5D的治疗方法,如针对复发性/耐药性MM的双特异性抗体和CAR T细胞.

关键词:
双特异性抗体 双特异性抗体化学抗原受体T细胞的T细胞.G蛋白结合受体类C组5组成员D免疫治疗是一种免疫疗法.多发性骨髓瘤是一种多发性骨髓瘤.

更多相关视频

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.0K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.4K

相关实验视频

Last Updated: Jun 11, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.8K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.0K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.4K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学

背景情况:

  • G蛋白结合受体类C组5成员D (GPRC5D) 在血细胞上显示近乎普遍的表达.
  • GPRC5D在必要的正常组织上表达有限,这使其成为一个有吸引力的免疫治疗点.
  • 多发性骨髓瘤 (MM) 仍然是一个重大挑战,特别是在复发/耐药的环境中.

研究的目的:

  • 审查GPRC5D的生物特征.
  • 总结针对GPRC5D的免疫疗法的转化进展.
  • 突出GPRC5D作为多发性骨髓瘤治疗点的潜力.

主要方法:

  • 审查关于GPRC5D的当前科学文献.
  • 对针对GPRC5D的向剂的临床前和临床数据的分析.
  • 综合有关治疗策略的信息,包括双特异性抗体 (BsAbs),仿真抗原受体 (CAR) T 细胞和抗体-药物合物 (ADC).

主要成果:

  • 针对GPRC5D的免疫疗法,包括BsAbs,CAR T细胞和ADCs,在复发性/耐药性MM (R/R MM) 中表现有前途.
  • GPRC5D的独特表达特征支持其作为高度特定的目标的潜力.
  • 目前正在进行的研究重点是优化这些疗法并探索组合策略.

结论:

  • 在多发性骨髓瘤中,GPRC5D是新型免疫疗法的可行和有前途的目标.
  • 进一步的临床试验对于建立长期疗效和最佳治疗模式至关重要.
  • 针对GPRC5D的组合疗法与其他抗原或现有治疗一起,可以克服MM耐药性.